Special Assistant to Prime Minister Imran Khan on National Health Services Dr. Zafar Mirza has said that a technical team in Pakistan will consider using Dexamethasone medicine to treat critically ill patients with COVID-19.
On Wednesday, in a tweeet, he pointed out the World Health Organization (WHO) has welcomed the initial clinical trial results from the United Kingdom that show dexamethasone can be lifesaving for patients who are at the last and citically ill with COVID-19.
Dr Zafar Mirza said it is an old and cheap anti-inflammatory medicine (steroid) and we have multiple producers in Pakistan.
Dr Zafar Mirza, however, warned dexamethasone is only for critically ill COVID-19 patients who are on oxygen and ventilators. He said the medicine must not be used by mild to moderate patients and that self-medication is strictly prohibited and can be dangerous as the medicine has many side-effects.